Amgen
$407.27Change from previous close: −3.38%Absolute change: −$14.24
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $220.18B
- Enterprise value
- $263.5B
- P/E (trailing 12 months)
- 25.3
- Forward P/E
- 16.7
- PEG
- 2.54
- Price/book
- 18.8
- Price/sales
- 5.78
- EV/EBITDA
- 15.3
- EV/revenue
- 6.92
Profitability and growth
- Gross margin
- 71.9%
- Operating margin
- 35.5%
- Net margin
- 23.0%
- ROE
- 91.5%
- ROA
- 8.7%
- Revenue growth (year over year)
- 9.5%
- Earnings growth (year over year)
- 64.9%
Financial health
- Total cash
- $13.99B
- Total debt
- $57.3B
- Debt/equity
- 4.90
- Current ratio
- 1.37
- Quick ratio
- 0.95
Dividends
- Annual dividend per share
- $10.08
- Dividend yield
- 2.5%
- Payout ratio
- 60.9%
- Ex-dividend date
- August 21, 2026
Analysts and estimates
- Average price target
- $390.94
- Median price target
- $400.00
- High price target
- $500.00
- Low price target
- $225.00
- Number of analysts
- 29
- Consensus
- Hold
- Forward EPS
- $24.45
- EPS estimate, current year
- $23.06
Shares and trading
- Beta
- 0.43
- Average volume
- 2.7M
- Shares outstanding
- 540.63M
- Float
- 539.16M
- Institutional ownership
- 85.0%
- Insider ownership
- 0.2%
- Short interest (% of float)
- 2.6%
- Short ratio (days)
- 5.40